Irreversible cell injury is primarily due to which of the following?
Secondary amyloidosis complicates which of the following conditions?
Apoptosis is characterized by all of the following EXCEPT?
Which of the following appearances will be seen in amyloidosis?
Which of the following cells do not act as antigen-presenting cells?
Which of the following is an autosomal dominant metabolic disorder?
Autopsy of the lung of an old man shows that the bronchi are lined by stratified squamous epithelium. What is this change?
A 90-year-old woman with mild diabetes and Alzheimer's disease dies in her sleep. At autopsy, hepatocytes are noted to contain golden cytoplasmic granules that do not stain with Prussian blue. Which of the following best accounts for pigment accumulation in the liver of this patient?
A middle-aged woman presented with a 6-month history of dull abdominal pain. A CT scan of the pelvis revealed a 7 cm mass involving the left ovary with irregular calcifications. The right fallopian tube and ovary were excised. What is the likely diagnosis?
Which of the following is true about trisomies?
Explanation: The transition from reversible to irreversible cell injury is defined by the "point of no return." While many biochemical changes occur during cell injury, the hallmark of **irreversibility** is the profound and permanent structural damage to cellular membranes and proteins [1]. **1. Why Option B is Correct:** Irreversible injury is characterized by two critical phenomena: **the inability to reverse mitochondrial dysfunction** (lack of ATP generation even after restoration of oxygen) and **profound disturbances in membrane function** [1]. Damage to the plasma membrane leads to the leakage of intracellular enzymes and cofactors; damage to lysosomal membranes results in the leakage of acid hydrolases into the cytoplasm, leading to enzymatic digestion of the cell (autolysis) [1]. **2. Why Other Options are Incorrect:** * **Option A:** A decrease in ATP is the *initial* event in most types of cell injury (especially hypoxia) [1]. However, if oxygen is restored, ATP levels can recover, making this a feature of reversible injury [1]. * **Option C:** Myelin figures are whorled phospholipid masses derived from damaged cell membranes. While they are more prominent in irreversible injury, they can also be seen in reversible injury as the cell attempts to sequester damaged lipids [1]. * **Option D:** Cellular swelling (hydropic change) is the **first manifestation** of almost all forms of cell injury [1]. It is a reversible process caused by the failure of energy-dependent ion pumps (Na+/K+ ATPase) [1]. **NEET-PG High-Yield Pearls:** * **Morphological Hallmarks of Irreversibility:** Severe mitochondrial vacuolization, amorphous nutrient-rich densities in the mitochondrial matrix, and nuclear changes (Pyknosis → Karyorrhexis → Karyolysis) [1]. * **Clinical Marker:** The leakage of intracellular proteins across damaged membranes is the basis for blood tests that detect tissue-specific injury (e.g., **Troponins** in MI, **ALT/AST** in hepatitis) [1]. * **Free Radicals:** Reactive Oxygen Species (ROS) are the primary mediators of membrane damage via lipid peroxidation. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 49-62.
Explanation: **Explanation:** **Secondary (AA) Amyloidosis** occurs as a complication of long-standing **chronic inflammatory conditions** [1]. The underlying mechanism involves the sustained elevation of **Serum Amyloid A (SAA)**, an acute-phase reactant produced by the liver under the influence of cytokines like IL-1 and IL-6 [1], [3]. Chronic inflammation leads to the proteolysis of SAA into AA amyloid fibrils, which deposit in organs such as the kidneys, liver, and spleen [1]. * **Why Chronic Osteomyelitis is correct:** It is a classic example of a chronic, persistent suppurative infection [1]. Other typical causes include Rheumatoid Arthritis (most common in the West), Tuberculosis, Bronchiectasis, and Inflammatory Bowel Disease (IBD) [1], [2]. * **Why other options are incorrect:** * **Pneumonia:** This is typically an acute infection. Amyloidosis requires months or years of sustained inflammation to develop [2]. * **Chronic Glomerulonephritis:** While this is a chronic condition, it is usually the *result* of amyloid deposition (renal amyloidosis), not the *cause* of it. * **Irritable Bowel Syndrome (IBS):** IBS is a functional disorder without significant systemic inflammation. In contrast, **IBD** (Crohn’s or Ulcerative Colitis) can cause secondary amyloidosis [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Stain of Choice:** Congo Red; shows **Apple-green birefringence** under polarized light. * **Most common organ involved:** Kidney (presents as Nephrotic Syndrome) [1]. * **Primary Amyloidosis (AL):** Associated with Plasma Cell Dyscrasias (Multiple Myeloma); consists of Immunoglobulin Light Chains [4]. * **Hemodialysis-associated Amyloidosis:** Involves **$\beta_2$-microglobulin** deposition, often presenting as Carpal Tunnel Syndrome [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 136-140. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 195-196. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 264-266. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 266-267.
Explanation: **Explanation:** Apoptosis is a form of **programmed cell death** designed to eliminate unwanted or damaged cells without harming the surrounding tissue [1]. **1. Why "Inflammation" is the correct answer:** Unlike necrosis, apoptosis is **not associated with inflammation** [2]. This is because the cell membrane remains intact throughout the process. The cell breaks down into membrane-bound "apoptotic bodies" which are rapidly phagocytosed by macrophages or neighboring cells [2]. Since intracellular contents (which act as DAMPs—Damage Associated Molecular Patterns) are not leaked into the extracellular space, no inflammatory response is triggered. **2. Analysis of Incorrect Options:** * **DNA Fragmentation (A):** This is a hallmark of apoptosis. Endonucleases cleave DNA into fragments of 180–200 base pairs, which appears as a characteristic **"Step-ladder pattern"** on agar gel electrophoresis. * **Chromatin Condensation (B):** This is the **most characteristic feature** of apoptosis. The chromatin aggregates peripherally under the nuclear membrane (pyknosis). * **Cell Shrinkage (C):** In apoptosis, the cell becomes smaller, the cytoplasm is dense, and organelles are tightly packed [2]. This contrasts with necrosis, where cells swell (oncosis). **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard for detection:** TUNEL assay (detects DNA fragmentation). * **Key Enzyme:** **Caspases** (Cysteine-aspartic proteases) [1]. Caspase-3 is the common executioner caspase. * **Morphological hallmark:** Formation of **Apoptotic bodies** [2]. * **Biochemical marker:** Translocation of **Phosphatidylserine** from the inner to the outer leaflet of the plasma membrane (recognized by Annexin V). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 63-65. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 67-69.
Explanation: **Explanation:** The correct answer is **X-ray crystallography** because it is the definitive method used to identify the unique physical structure of amyloid. **1. Why X-ray Crystallography is Correct:** Amyloid is not a single chemical entity but a protein folding disorder [1]. Regardless of the protein type (AL, AA, or Transthyretin), all amyloid fibrils share a common structural configuration: the **Cross-β-pleated sheet** [1]. X-ray crystallography (and infrared spectroscopy) reveals this specific pattern, which is responsible for the characteristic staining properties and resistance to degradation seen in amyloidosis. **2. Analysis of Incorrect Options:** * **B. Electron Microscope:** While EM shows amyloid as non-branching, linear fibrils (7.5–10 nm diameter) [2], it does not reveal the "appearance" of the molecular β-pleated structure itself [1]. * **C. Spiral Electron Microscope:** This is a distractor term; standard transmission electron microscopy (TEM) is the modality used for fibril visualization. * **D. Congo Red Stain:** This is a histological stain, not an "appearance." While it is the gold standard for diagnosis, the question specifically targets the structural configuration identified via crystallography. Under polarized light, Congo red-stained amyloid shows **Apple-green birefringence** [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard for Diagnosis:** Congo Red stain (shows Apple-green birefringence) [1]. * **Most Common Type (Systemic):** AL amyloidosis (Light chain) [5]. * **Most Common Type (Secondary/Inflammatory):** AA amyloidosis (Serum Amyloid Associated) [4]. * **H&E Appearance:** Extracellular, homogenous, eosinophilic (pink) amorphous material [1]. * **Scintigraphy:** $^{123}$I-labeled SAP (Serum Amyloid P) component scan can be used to localize deposits [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 268-269. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 135-136. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 264-266. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 136-140. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 266-267.
Explanation: **Explanation:** Antigen-presenting cells (APCs) are specialized immune cells that capture antigens, process them into peptides, and display them on their surface via **MHC Class II molecules** to activate T-lymphocytes [1]. **1. Why T-cells (Option A) is the correct answer:** T-cells are the **recipients** of antigen presentation, not the providers. They possess T-cell receptors (TCRs) that recognize antigens presented by other cells [2]. While T-cells are central to cell-mediated immunity, they do not express MHC Class II constitutively to prime other naive T-cells; therefore, they do not function as APCs. **2. Analysis of Incorrect Options:** * **B-cells (Option B):** These are "Professional APCs." They internalize specific antigens via their B-cell receptors (BCR) and present them to Helper T-cells to receive signals for antibody production and isotype switching [1]. * **Macrophages (Option C):** These are classic "Professional APCs." They phagocytose pathogens and present the processed peptides to T-cells to initiate an immune response [1]. * **Osteoclasts (Option D):** These are derived from the **monocyte-macrophage lineage**. Recent immunological studies have confirmed that osteoclasts can express MHC Class II and costimulatory molecules, allowing them to act as "non-professional" or specialized APCs within the bone microenvironment. **Clinical Pearls for NEET-PG:** * **Professional APCs:** Dendritic cells (most potent), Macrophages, and B-cells [1]. * **Dendritic Cells:** The only APCs capable of activating **naive** T-cells [3]. * **Langerhans Cells:** Specialized dendritic cells found in the stratum spinosum of the epidermis. * **MHC Requirement:** All APCs must express **MHC Class II** to interact with CD4+ Helper T-cells. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 207-208. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 198-199. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 204-206.
Explanation: ### Explanation **Correct Option: D. Familial Hypercholesterolemia** **Why it is correct:** Familial Hypercholesterolemia (FH) is a classic example of an **Autosomal Dominant (AD)** metabolic disorder [1]. It is caused by mutations in the **LDLR gene**, which encodes the Low-Density Lipoprotein (LDL) receptor [1]. This defect leads to impaired hepatic uptake of LDL, resulting in extreme elevations of plasma cholesterol [1]. Unlike most metabolic disorders (which are typically recessive due to the "margin of safety" in enzyme levels), FH follows a dominant pattern because a 50% reduction in receptors (heterozygous state) is insufficient to maintain normal cholesterol homeostasis, leading to premature atherosclerosis and xanthomas [1], [4]. **Why the other options are incorrect:** * **A. Cystic Fibrosis:** This is an **Autosomal Recessive (AR)** disorder caused by mutations in the *CFTR* gene [2]. It affects chloride ion transport in exocrine glands. * **B. Phenylketonuria (PKU):** This is an **AR** metabolic disorder involving a deficiency of the enzyme phenylalanine hydroxylase [2], [3]. Most inborn errors of metabolism involving enzyme deficiencies are recessive [4]. * **C. Alpha-1 Anti-trypsin (AAT) Deficiency:** This is inherited in an **Autosomal Co-dominant** fashion (though often categorized with AR disorders in simplified contexts) [2]. The *SERPINA1* gene alleles (M, S, Z) determine the serum levels of the protease inhibitor. **NEET-PG High-Yield Pearls:** 1. **Rule of Thumb:** Most structural protein defects are **AD**, while most enzyme deficiencies are **AR** [4]. 2. **Exceptions (AD Metabolic Disorders):** Familial Hypercholesterolemia and Acute Intermittent Porphyria (AIP). 3. **Clinical Sign:** Look for **Tendon Xanthomas** (especially the Achilles tendon) and **Xanthelasma** in FH cases. 4. **Genetics:** Homozygous FH is rare and severe, often leading to myocardial infarction before age 20 [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 151-159. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 150-151. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 119-120. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 57-58.
Explanation: ### Explanation **Correct Answer: A. Metaplasia** **Concept:** Metaplasia is a **reversible change** in which one differentiated cell type (epithelial or mesenchymal) is replaced by another differentiated cell type [1]. It is an adaptive response to chronic irritation or stress [3]. In the respiratory tract of chronic smokers or elderly individuals exposed to pollutants, the normal **pseudostratified ciliated columnar epithelium** is replaced by **stratified squamous epithelium** [1], [3]. While the new squamous cells are more rugged and resistant to irritation, the vital protective functions of the original cells (mucus secretion and ciliary action) are lost [1]. **Why other options are incorrect:** * **B. Dysplasia:** This refers to disordered growth characterized by a loss of cellular uniformity and architectural orientation [2]. While metaplasia can progress to dysplasia if the stimulus persists, the simple replacement of one mature cell type with another is metaplasia. * **C. Hyperplasia:** This is an increase in the **number of cells** in an organ or tissue, usually resulting in increased volume [2]. It does not involve a change in cell type. * **D. Hypertrophy:** This is an increase in the **size of cells**, resulting in an increase in the size of the organ. It occurs in cells with limited capacity to divide (e.g., cardiac muscle). **High-Yield Clinical Pearls for NEET-PG:** * **Most common type:** Squamous metaplasia (e.g., Bronchus in smokers, Endocervix in chronic cervicitis) [3]. * **Barrett’s Esophagus:** A classic example of **Columnar Metaplasia**, where squamous epithelium of the esophagus changes to columnar (intestinal) epithelium due to acid reflux. * **Vitamin A Deficiency:** Can induce squamous metaplasia in the respiratory tract and ducts of glands. * **Reversibility:** Metaplasia is reversible if the inciting stimulus is removed [1]. However, persistent metaplasia is a fertile soil for **malignant transformation** [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 49. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, p. 723. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 91-92.
Explanation: ### Explanation The golden-brown cytoplasmic granules described are **Lipofuscin**, also known as the "wear-and-tear" or "aging" pigment. **1. Why "Advanced Age" is Correct:** Lipofuscin is an insoluble pigment composed of polymers of lipids and phospholipids complexed with protein [1]. It is a tell-tale sign of **free radical injury and lipid peroxidation** [3]. As cells age or undergo atrophy, autophagic vacuoles fuse with lysosomes to digest cellular components [3]. The indigestible residues remain in the cytoplasm as lipofuscin. It is most commonly seen in permanent or stable cells (heart, liver, and brain) of elderly patients [1]. The fact that it is **Prussian blue negative** distinguishes it from Hemosiderin (iron), which would stain positive [2]. **2. Why the Other Options are Incorrect:** * **Alzheimer’s Disease:** While associated with aging, the characteristic pathological findings are extracellular amyloid-beta plaques and intracellular tau tangles, not generalized hepatic lipofuscin. * **Congestive Heart Failure (CHF):** Chronic passive congestion of the liver leads to a "nutmeg liver" appearance. While it can cause centrilobular necrosis and hemosiderin deposition (which *is* Prussian blue positive) [2], it is not the primary cause of generalized lipofuscinosis. * **Diabetic Ketoacidosis (DKA):** This is an acute metabolic complication. It does not cause the chronic, progressive accumulation of lipid peroxidation products seen in this patient. **3. NEET-PG High-Yield Pearls:** * **Lipofuscin:** Derived from "Lipo" (fat) and "fuscus" (brown). It is **not** harmful to the cell itself but serves as a marker of past free radical damage [4]. * **Brown Atrophy:** When lipofuscin accumulation is extensive in an organ (like the heart), the organ shrinks and takes on a brown discoloration, a condition termed "brown atrophy." * **Staining:** Lipofuscin is naturally pigmented (golden-brown). Unlike **Hemosiderin** (Prussian Blue +) or **Melanin** (Masson-Fontana +), lipofuscin does not have a specific diagnostic stain but is identified by its characteristic color and perinuclear location [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 75. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 854-855. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 241-242. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 77.
Explanation: **Explanation:** The clinical presentation of a middle-aged woman with a slow-growing ovarian mass containing **irregular calcifications** is highly suggestive of a **Mature Cystic Teratoma (Dermoid Cyst)**. **1. Why Mature Cystic Teratoma is correct:** Mature cystic teratomas are the most common germ cell tumors, typically occurring in women of reproductive age [2]. They are composed of well-differentiated tissues derived from at least two of the three germ layers (ectoderm, mesoderm, and endoderm) [1]. The "irregular calcifications" noted on the CT scan represent **teeth or bone formation** (mesodermal components), which is a classic radiological and pathological hallmark of this tumor [1], [2]. **2. Why other options are incorrect:** * **Mucinous cystadenoma:** These are large, multiloculated cystic masses filled with gelatinous fluid. While they may have thin septal calcifications, they do not typically present with the dense, irregular calcifications (bone/teeth) characteristic of teratomas [1]. * **Choriocarcinoma:** This is a highly aggressive, gestational trophoblastic neoplasm characterized by rapid growth, early hematogenous metastasis, and markedly elevated **β-hCG**. It presents with hemorrhage and necrosis rather than calcification. * **Dysgerminoma:** This is the female counterpart of seminoma. While it may show speckled calcifications in some cases, it is more classically associated with elevated **LDH** and a solid, "fleshy" appearance rather than the complex, calcified features of a teratoma. **High-Yield Clinical Pearls for NEET-PG:** * **Rokitansky Protuberance:** A solid nodule projecting into the cyst cavity of a teratoma, often containing hair and teeth. * **Complication:** The most common complication is **ovarian torsion**. * **Malignant Transformation:** Occurs in <2% of cases, most commonly into **Squamous Cell Carcinoma** [1]. * **Radiology:** The presence of fat (sebaceous material) and calcium on CT is pathognomonic [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1033-1034. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Female Genital Tract Disease, pp. 480-481.
Explanation: **Explanation:** Trisomies occur due to **meiotic non-disjunction**, where chromosomes fail to separate during gametogenesis, resulting in a zygote with three copies of a specific chromosome instead of two. * **Option A:** Advanced maternal age (typically >35 years) is the most significant risk factor for trisomies, particularly Down syndrome [1]. This is attributed to the prolonged arrest of maternal oocytes in Prophase I (Dictyotene stage), making them more susceptible to non-disjunction events over time. * **Option B:** Down syndrome (Trisomy 21) is the leading genetic cause of intellectual disability (mental retardation) [2]. It is characterized by a specific phenotype including IQ scores typically ranging from 25 to 50, along with structural brain changes [2]. * **Option C:** Trisomy 21 is the most common chromosomal abnormality among live births [1]. While Trisomy 16 is actually the most common trisomy found in spontaneous abortions, Trisomy 21 is the most prevalent in the surviving population [1]. Since all statements are factually correct, **Option D** is the right answer. **High-Yield NEET-PG Pearls:** 1. **Most common trisomy in spontaneous abortions:** Trisomy 16 [1]. 2. **Edward Syndrome:** Trisomy 18 (Features: Rocker bottom feet, Clenched fists, Micrognathia) [2]. 3. **Patau Syndrome:** Trisomy 13 (Features: Polydactyly, Cleft lip/palate, Holoprosencephaly) [2]. 4. **Down Syndrome Markers:** Low AFP, low unconjugated estriol (uE3), and high hCG/Inhibin A in the maternal quadruple screen. 5. **Most common cause of Down Syndrome:** Meiotic non-disjunction (95% of cases), followed by Robertsonian translocation [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 40-41; 92-93. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 168-172.
Cell Injury and Cell Death
Practice Questions
Adaptations of Cellular Growth
Practice Questions
Accumulations and Deposits
Practice Questions
Acute and Chronic Inflammation
Practice Questions
Tissue Repair and Wound Healing
Practice Questions
Hemodynamic Disorders
Practice Questions
Genetic Disorders
Practice Questions
Environmental Pathology
Practice Questions
Nutritional Diseases
Practice Questions
Molecular Basis of Disease
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free